Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 17, 387-398, June 1, 1957]
© 1957 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, J. A.
Right arrow Articles by Finger, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, J. A.
Right arrow Articles by Finger, G. C.

Further Studies on the Carcinogenicity of Dyes Related to 4-Dimethylaminoazobenzene. The Requirement for an Unsubstituted 2-Position*

J. A. Miller, E. C. Miller and G. C. Finger

( McArdle Memorial Laboratory, Medical School, University of Wisconsin, Madison, Wis., and the Division of Fluorine Chemistry, Illinois State Geological Survey, Urbana, Ill.)

A study of the carcinogenicities of various fluoro and other derivatives of 4-dimethylaminoazobenzene (DAB) in the rat liver has indicated that an unsubstituted 2-position in this dye is necessary for carcinogenic activity.

The following compounds had moderate to strong carcinogenic activity: 3-fluoro-DAB, 3',4'-difluoro-DAB, 2,5,2',5'-tetrafluoro-DAB, 2'-methoxy-DAB, 3'-methoxy-DAB, 4'-methoxy-DAB, and 4'-ethyl-DAB.

The following compounds had only weak carcinogenic activity: 3-methyl-DAB, 2-methyl-4-monomethylaminoazobenzene, and 3',4'-dimethyl-DAB.

The following compounds had no detectable carcinogenic activity: 2,6-difluoro-DAB, 2,6,3',5'-tetrafluoro-DAB, 2,6,2',4',6'-pentafluoro-DAB, 3-hydroxy-DAB, DAB methochloride, 2-acetylamino-5-dimethylaminodiphenylamine, 2-nitro-5-dimethylaminodiphenylamine, 3,4-dinitrodimethylaniline, 4'-amino-4-dimethylaminodiphenylamine, 4'-imino-4-dimethylaminodiphenylimine sulfate, benzo[c]cinnoline, 2-dimethylaminobenzo[c]cinnoline, the dihydrochloride and N-acetyl derivative of N,N-dimethyl-p-phenylene diamine, aniline hydrochloride, N-acetyl m-toluidine, sodium p-dimethylaminobenzene diazonium sulfonate, and 4,4'-bis(dimethylamino)azobenzene.

The syntheses of several new derivatives of DAB are described. These are 3-fluoro-, 2,6-difluoro-,3',4'-difluoro-, 2,5,2',5'-tetrafluoro-, 2,6,3',-5'-tetrafluoro-, 2,6,2',4',6'-pentafluoro-, 3'-methoxy-, 4'-ethyl-, 3',4'-dimethyl-, and 3-hydroxy-DAB.

* This investigation was supported in part by grant C355 of the National Cancer Institute, U.S. Public Health Service, Institutional Grant 71 from the American Cancer Society, and the Alexander and Margaret Stewart Trust Fund.

Received 12/31/56.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1957 by the American Association for Cancer Research.